Construction of porcine CCK pDNA and its expression in COS-7 cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 27, Issue 3, 2007, Pages 278-280

  Bai, Jigang ^a   Lü, Yi ^a   Bai, Qiaoling ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b Shaanxi Cancer Hospital   (China)

Author keywords

Cell transfection; Cholecystokinin; COS 7 cells; Green fluorescent protein; RT PCR

Indexed keywords

CHOLECYSTOKININ; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MESSENGER RNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN COS1; CERCOPITHECUS; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE;

ANIMALS; CERCOPITHECUS AETHIOPS; CHOLECYSTOKININ; COS CELLS; DNA, COMPLEMENTARY; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE; TRANSFECTION;

EID: 34547355029     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-007-0315-7     Document Type: Article

References (10)

1. Rehfeld J F, Sun G, Christensen T et al. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab, 2001,86(1):251-258
2. Hirata M, Itoh M, Tsuchida A et al. Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS Lett, 1996,383(3):241-244
3. Hirata M, Tsuchida A, Iwao T et al. Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway. Int J Oncol, 1999,14(6):1129-1135
4. Aly A, Shulkes A, Baldwin G S. Gastrins, cholecystokinins and gastrointestinal cancer. Biochim Biophys Acta, 2004,1704(1):1-10
5. Michaud D S. Epidemiology of pancreatic cancer. Minerva Chir, 2004,59(2):99-111
6. Yeo C J. Pancreatic cancer: 1998 update. J Am Coll Surg, 1998,187(4):429-442
7. Tighe H, Corr M, Roman M et al. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today, 1998,19(2):89-97
8. Bergman P J, McKnight J, Novosad A et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin Cancer Res, 2003,9(4):1284-1290
9. Weber L W, Bowne W B, Wolchok J D. Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest, 1998,102(6):1258- 1264
10. Wei Y Q. Immunotherapy of tumors with vaccines based on xenogeneic homologous molecules. Anticancer Drugs (Chinese), 2002,13(3):229-235